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Implementing disruptive technological change in UK healthcare: exploring the 





Developing and applying technological innovations in healthcare is a complex and 
uncertain process, due to the many surprising and unexpected effects upon the 
practices, perspectives and interests of the variety of professional and managerial 
stakeholders involved. In this paper, we draw upon the concept of boundary object to 
explore processes of collaboration, knowledge transformation and learning associated 
with the development, use and (prospective) wider diffusion in the English healthcare 
system of a particular type of healthcare innovation: a smart phone app for use by 
rheumatoid arthritis patients. Taking into account that technological artefacts can both 
enable and inhibit collaboration, as well as evolve during their development, we 
explore the challenges of overcoming tensions between the transformative and 
learning capabilities of such technological artefacts and the inhibitions that these 




The paper is directly concerned with understanding the complexities and challenges 
of change in the healthcare context and specifically focuses upon the role of 
healthcare technology. It focuses upon the development and application of a particular 
novel technology within healthcare organizations, addressing how the development, 
adoption and implementation processes associated with the technology affected the 
various professional, managerial and patient groups involved or implicated in its 
design, delivery and use. It particularly concentrates upon understanding relationships 
between these groups as they were mediated through the technological object and 
the impact of technical innovation upon their (changing) knowledge and practices. In 
doing so, it examines some of the complex and surprising ways in which the 
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development of a particular technological artefact (in this case a smart phone app for 
patients’ self-monitoring of rheumatoid arthritis) both reflects and, in turn, challenges 
the expectations, interests, influence and practices of key stakeholders involved in its 
design, development and use. 
 
The purpose of this paper is therefore to examine the challenges associated with the 
development and implementation of new, disruptive forms of technological innovation 
in healthcare associated mobile phone technology. The specific case focused on is 
the development, implementation and use in an English hospital of a smart phone app 
for the use of patients with rheumatoid arthritis, whose data could be integrated into 
their electronic health record (EHR) and visible to clinicians during clinical 
consultations. The app was designed to enable more real-time monitoring of patient 
symptoms by patients themselves and to allow more bespoke individual treatment and 
targeted clinical consultations and interventions.  
 
Developing and embedding such a technological innovation is a complex endeavour 
(Deering et al., 2013) and in this case involved contributions from various stakeholder 
groups including patients, clinical researchers, clinicians, practitioners (nurses, 
physios), software developers, hospital information technology (IT) specialists and 
hospital managers. In this paper we explore the complex inter-relationship between 
the co-production processes involved in the development of this innovation and the 
perspectives, interests and (changing) influence and practices of those stakeholders 
during its development and use. Drawing upon an empirical study which involved 
interviews and recorded clinical consultations with these stakeholders, we assess the 
wider implications for understanding the challenges associated with diffusing and 
embedding new IT innovations to support management of long term conditions within 
healthcare organizations and systems. 
 
We do this by exploring the app, and the system of related objects involved in its 
development, as boundary objects (Star and Griesemer, 1989), considering its 
capabilities and limitations of integrating systems of knowledge and learning 
(e.g.Boland and Tenkasi, 1995; (Carlile, 2004 (Carlile, 2002) (Swan et al., 2007)). In 
brief, boundary objects assist individuals from different disciplines in translating or 
transforming information across disciplinary boundaries (Carlile, 2002) whilst allowing 
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each party to maintain their individual perspectives (Star and Griesemer, 1989). Three 
boundaries are of particular interest here: between development of the innovation and 
its use in practice; between the illness management led by the patient at home and 
that planned in the clinic; and between the implementation of the app from a single 




The challenges and complexities associated with diffusing and implementing 
technological change in healthcare have been studied extensively (e.g. Barrett and 
Oborn, 2010; Petrakaki et al, 2014). Indeed, research continues consistently to 
highlight not only the opportunities provided by innovations in technology – particularly 
those associated with information and communication technologies – but also the 
considerable difficulties involved in implementing and exploiting them in practice. This 
is due to the many unexpected challenges that arise in embedding them in and 
organizational systems due to the disruptive effects they might have upon professional 
and managerial practices (e.g. Lehouxa et al, 2012).  
 
Research on technological innovations within healthcare has recently directed 
considerable attention towards understanding the role of technological artefacts – 
including both electronic and paper-based information systems – as boundary objects 
(Swan et al., 2007; Smith and Ward, 2015). Particular stress has been put on the 
integrative potential of systems such as electronic patient records (Saario et al., 2012) 
and magnetic resonance imaging (Reed et al., 2016) in helping bridge professional 
communities of practice in healthcare. Technological artefacts have also been shown 
to be important in connecting mainstream healthcare with complementary and 
alternative medicine (Keshet et al., 2013; Owens, 2015). However, a good deal of 
research has also emphasised the capacity of innovations – such as the development 
of new care pathways – to reinforce professional boundaries and barriers to interaction 
between professional groups (Allen, 2014; Hunter and Segrott, 2014).  
 
Importantly, technological systems such as electronic health records (EHR) and 
electronic prescription services (EPS) can have disruptive effects on existing 
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professional work, practices and domains (Motulsky et al., 2011; Petrakaki et al., 2012, 
2014; Reich, 2012). That means professional practices, norms and interests can be 
challenged and may need to be accommodated through the negotiation of interests in 
the development or implementation of new systems (Lehouxa et al., 2012; 
Constantinidis and Barrett, 2006). In turn, this inevitably creates considerable 
challenges to those attempting to develop, apply and diffuse such technological 
systems throughout healthcare organizations and across wider healthcare systems 
(Pols and Willems, 2011). Moreover, those challenges are magnified insofar as 
innovations in healthcare, particularly in telemedicine or through the use of mobile 
phone technology, also involve bridging the clinician-patient interface with all the 
complexities that brings for attempting to transform patient behaviour (Oudshoorn, 
2008; Mol et al, 2010). 
 
Stemming originally from the work of Star and Griesemer (1989), the concept of 
boundary objects has been used widely to help understand the ways in which 
knowledge is created, shared and integrated across boundaries of practice between 
specialist groups engaged in joint activity ((Boland Jr and Tenkasi, 1995), 1995; 
Carlile, 2002, 2004; Boland et al, 2007 (Boland Jr et al., 2007)). Crucially, the defining 
characteristic of boundary objects is that they have some interpretative flexibility or 
‘plasticity’ (Star and Greisemer, 1989), which allows different groups engaged in 
distributed practices to interact with one another and to engage in joint activity – in the 
process, sharing or transforming their knowledge and practices (Carlile, 2002).  
 
Research in this tradition has explored the use of various management systems, tools 
and techniques as boundary objects. Information systems have long been seen and 
conceived of as boundary objects (Levina and Vaast, 2005; Barrett and Oborn, 2010), 
since their specification and development presupposes the need for knowledge 
sharing across boundaries (Ewenstein and Whyte, 2009) and their operation directly 
involves flows of information and knowledge between inter-connected communities of 
practice. The focal partnership between clinician and patient in our case, may be 
viewed as one particular dyadic relationship which forms a boundary across which 
boundary objects may assist integration, knowledge transformation and learning. 
Other relevant boundaries may concern those linking actors involved in the 
development of the technological application itself (researchers, clinicians, software 
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developers, etc) and those concerned with its wider implementation and diffusion 
(practitioners, IT specialists and hospital managers). 
  
While research has tended to emphasize the integrative possibilities afforded by 
boundary objects in bridging knowledge boundaries and facilitating joint knowledge 
sharing and creation (e.g. Star and Griesemer, 1989; (Boland Jr and Tenkasi, 1995)), 
more recent research has started to question their presumed ‘neutral’ qualities and 
‘immutable’ characteristics. Increasing emphasis has been put instead upon 
understanding boundary objects as being not fixed or static, nor as neutral in how they 
shape action, but as flexible in how they are used over time such that they serve 
different purposes over the course of a particular collaboration (Nicolini 2011; Nicolini 
et al, 2012). Emphasis has also been placed on the role that boundary objects play 
when they are designed with the aim of aiding collaboration, and how they might 
evolve from being ‘designated boundary objects’ to ‘boundary objects-in-use’, 
integrated into everyday practice (Levina and Vaast, 2005). 
 
Recent work has emphasized the importance of understanding the 
interconnectedness associated with systems of boundary objects that together 
facilitate processes of innovation and R&D. Traditionally, boundary objects have been 
seen as relatively stable and singular. However, recent work has moved away from 
this reliance on assuming that collaboration derives somehow from the essential 
nature of individual objects themselves and has looked instead at the set of objects 
and relations in which they occur. 
 
Based on research in a case study of biomedical innovation, Nicolini et al (2012) make 
a particularly important contribution by proposing a three-level ‘hierarchy’ of objects. 
They differentiate between tertiary objects (that provide the infrastructure for 
collaboration, including built environment and electronic systems); secondary objects 
(that are the classic boundary objects found in drawings, design objects, etc); and 
primary objects (which are more fundamental and epistemic in nature and so which 
help inspire, motivate and sustain collaboration). They also demonstrate how such 
objects can develop and change in their role and use over time (e.g. from being an 
integrating idea that crystallizes into a more material object that helps further design 




Scarbrough et al (2015) have built upon this idea further by emphasizing the relational 
qualities of how such objects inter-connect and how collaboration and coordination 
occur not just through the use of a variety of objects , but also through the complex 
(and evolving) links between them. They describe this as a system of objects, whose 
inter-connectedness ‘orchestrates’ collaborative tasks (ibid: 217-8). As they put it: 
 
… the capacity of the shared objects in our study to support coordination over 
time, and across multiple collaborative tasks, emerged not from their use 
independently, but rather from the routine way in which shared objects were 
inter-related and cross-referenced, with changes in one object prompting work 
to revise and update other objects. By maintaining these relations, the process-
level coordination of work activities could be achieved, even in the face of an 
uncertain and emergent innovation process” (ibid: 212) 
 
An important further strand of research emphasizes too how boundary objects are 
inscribed with relations of power, insofar as their design embodies a particular 
configuration of power/knowledge that may reflect dominant interests and 
perspectives and so prescribe or limit action (Thomas et al., 2008; Oswick and 
Robertson, 2009). As such, boundary objects can both facilitate and inhibit knowledge 
sharing and learning throughout the course of any interaction, since they are inscribed 
with meanings that shift as power dynamics and negotiations over their use unfold, 
thus enabling or hindering interaction, dependent upon their mobilization (Barrett and 
Oborn, 2010) and engagement by participants (Allen, 2014). 
 
Consequently, it is as important to be aware too of the ways in which boundary objects 
can hinder, as much as facilitate, joint action. Moreover, it is also important to be open 
to exploring how their use may be associated with the empowering or disempowering 
of particular groups and what that means for established professional and 
management practices. In this paper, we therefore present a more nuanced, situated 
and dynamic interpretation of interaction around technological systems as boundary 
objects in the healthcare context, exploring how they can simultaneously enable and 
hinder integration, through the recursive iterations and associated social interaction 
that occurs in their development and use. This points to the possibility not only that 
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they may create tensions in their effects on particular groups, but also that these 
tensions may play out in ways that lead to the suppression and later activation of latent 
conflicts of interest or perspective – with implications for the stability, maintenance and 
generalizability of collaborative action centred around those particular objects.   
 
In what follows, we therefore explore the unfolding development, use and (prospects 
for) wider implementation and diffusion of a mobile phone based technological 
innovation, focusing particularly upon its evolving and changing role within a wider 
localized system of objects and relations amongst the multiple stakeholder groups 
involved (clinicians, patients, researchers, software developers, IT specialist and 
hospital managers). Our case uses the development and use of a smartphone app, 
whose data are integrated into patients’ electronic health records (EHR) in graphical 
form. We examine how its interconnected components acted as a system of boundary 
objects to help facilitate the crossing of three different types of boundary: between 
groups involved in its development; between clinician and patient in its use; and with 
actors representing wider organizational perspectives and interests. Our analysis 
questions the impact upon collaboration across these boundaries, the effects upon the 





The research in this paper is case study based (Eisenhardt and Graebner, 2007) 
(Eisenhardt and Graebner, 2007) and draws from qualitative data collected from a 
range of stakeholder groups involved in the practical development, application and 
use of a smart-phone app (for Android phones) to be used by patients for self-
monitoring and reporting of rheumatoid arthritis (RA) symptoms. In total, data from 39 
semi-structured interviews and two focus groups with patients, healthcare 
professionals, IT specialists and managers were collected and analyzed, in addition 
to 17 audio-recorded clinical consultation transcripts (see Table 1). Data were taken 
from two time points; one during app development and prior to its implementation (‘pre-




TABLE 1 ABOUT HERE 
 
The wider study, of which the interviews, focus groups and clinical consultations 
formed a part, was undertaken over a two-year period. The study had three main aims, 
the first two of which are of relevance to this paper. Firstly, to develop an app which 
would enable patients to collect real time data on their daily, weekly and monthly 
rheumatoid arthritis symptoms. Secondly, to enable novel integration of the data from 
the app into graphical form within the results section of the EHR, for use during clinical 
consultations between patients and their healthcare professionals. And thirdly, to 
create a rich dataset of patient reported outcomes on rheumatoid arthritis disease 
activity for research purposes. 
 
The importance of the study lay in the fact that rheumatoid arthritis is a long-term 
condition, which fluctuates over time. The current model of care is for patients to see 
healthcare professionals sporadically (approximately six-monthly for stable patients). 
These sporadic interactions provide only a static snapshot of the illness and are 
heavily reliant on patient recall of the intervening period. The possibility of recall 
problems (inaccurate reporting of events), has implications for continuing patient care 
and an issue that is well-documented in the medical literature (Shiffman et al., 2008). 
In the meantime, patients are also left to manage their symptoms themselves.  
 
The app was developed with direct patient involvement in its design, development and 
testing, and was led by a multi-disciplinary project steering group consisting of 
researchers, clinicians and project managers (which included all authors of this paper). 
Initial plans for the app were presented to stakeholders who were interviewed as part 
of the research process, with findings being fed back to the steering group in real time 
to inform the design and integration of the app. Project managers liaised with a 
University-based software development team to develop the app and with a hospital-
based informatics team to integrate graphed patient reported outcomes into the EHR. 
Clinician researchers held consultations with RA patients who had used the app. The 
hospital trust hosting the research was a digitally mature site, which is of relevance 




This paper draws on the semi-structured interviews and focus groups conducted with 
the various stakeholder groups involved. Interactions during the course of the project 
explored these groups’ perspectives on the app and its development, focusing upon 
the handling of critical interfaces between different interests, perspectives and 
practices during both the development of the app and its subsequent use and 
interconnection with the supporting IT infrastructure. Initial, inductive coding was 
conducted separately by three members of the research team, using NVivo. The 
proximity of the authors to the project allowed for deeper insights to be drawn, but also 
prompted the need for care to be taken to ensure reflexivity during analysis. 
Comparison of emerging themes was made, with adjustments taking place at 
meetings between the team. Having data from such a range of stakeholder groups 
allowed for some comparison of themes across groups and broadened out the 





The section presents qualitative data from the interviews that explored stakeholder 
perspectives, interests and actions as they evolved and interacted across the three 
boundaries of interest, namely: 
 
1. Boundary between technical development of the innovation and its application 
to clinical practice  
2. Boundary between the illness management led by the patient at home, and that 
planned in the clinic 
3. Boundary between the implementation of the app from a single research project 
to its wider scaling up and diffusion 
 
Table 2 summarizes key features of the responses of five of the main stakeholder 
groups at each of these stages. 
 




Analysis of the data highlights a number of ways in which developing the app and 
integrating it with clinical and hospital systems and practices variously reflected, 
reinforced or challenged different groups’ interests and perspectives, thus generating 
tensions that needed effective handling. In particular, the summary table highlights a 
number of principal areas in which the development of the app disrupted existing 
practices and created challenges that needed some form of resolution. In particular: 
 
 Through attempting to embed diagnostics within existing clinical pathways, 
systems and practices 
 Through engaging users (patients) and encouraging them to move to a more 
self-help approach 
 Through integrating data flows associated with a bespoke system with the wider 
standardized hospital IT system design 
 
Important implications are drawn out from the analysis below for the effects on clinical 
practice and patient engagement, for the diffusion of the innovation in practice, and for 
the generalizability of the app-based system to other disease areas and other 
healthcare organizations.  
 
Boundary between technical innovation and clinical practice  
 
Developing the innovation and integrating it into existing IT and clinical systems 
involved navigating the boundary between innovation and practice. Project 
management of the app’s development and implementation involved a number of 
different stakeholder groups. These included users (patients – predominantly using 
the app; and clinicians – predominantly using the graphed results in the EHR), as well 
as designers (app software developers and hospital IT staff working on the EHR) and 
hospital managers. Here, we explore firstly the needs of patients and clinicians, and 
how these were mediated. Secondly, we explore how the clarity of both the roles of 
individual stakeholders, and the project specification, were perceived to be key to the 
project’s success.  
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Patient input into design 
The research team proposed the initial design of the innovation, upon which patients 
were asked to comment. Key needs expressed by patients were to be able to use the 
app to identify factors that influenced their illness (e.g. triggers for fluctuations in 
disease severity) and the ability to use the app as a ‘confidante’. Patients initially 
preferred to enter data only when something notable happened. In contrast, 
practitioners preferred to collect as much data as possible, encouraging the use of 
daily data capture (for both clinical and research purposes). However, practitioners 
anticipated the potential burden of regular data capture, which highlights the potential 
for negotiation:  
 
[Researcher 12]: …so there is finding the balance with the recall period and how 
much people are willing to sort of enter some of the information.   
 
These potential tensions were mediated through compromise in the app’s design. 
Patients were willing to input data more regularly, particularly if reminder functions 
were incorporated into the app; and the inclusion of a free-text diary function with the 
potential to fulfil the role of confidante was introduced. 
Clarity of role 
Clarity of roles within the project management team was felt to be important, 
highlighting the disciplinary differences and resulting boundaries between different 
stakeholder groups:  
 
[IT Specialist 13]: There’s two different worlds and it’s difficult to know from 
people’s job titles and things who I needed to speak to.  I think that was the 
biggest thing.  Eventually we thrashed out a solution where we published 
everybody’s roles on a Google document that was freely available to all of 
us and then that got better.  I still feel that more understanding of their world 
would have been beneficial. 
 
Recognizing the potentially significant impact of these differences, participants 
placed an emphasis on the need for individuals to play a brokering role, rather than 
being embedded within their own separate organization. So, for example, members 
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of the research team, who might otherwise have been seen as ‘external’ to the IT 
staff, were instead embedded within the project: 
 
[IT Specialist 5]: We’re not going to give [the app project] to an IT Project 
Manager, we’re just going to give a person who can, sort of, link people 
together.  So, obviously, if [name] has a problem, he doesn’t know who to 
go to, whereas this person will be able to say you need to speak to X, Y or 
Z, nothing will change. 
[IT Specialist 5]: Because people were aware of what [brokering applied 
healthcare research organization] was in IT, because we’ve dealt with them 
before, we’ve done other projects.  So that visibility was there, it wasn’t like 
it was an outside, third party person coming in saying: ‘I want this, I want 
this.’  It was somebody that was perceived as working here. 
Clarity of specification 
Issues arose around the scope and expectation of those charged with developing the 
app.  IT staff reported that establishing clarity of specification, particularly in the early 
stages of the project, could be frustrating, given the very different expectations and 
approaches in play and the need to manage those expectations across boundaries:  
 
[IT Specialist 6]: It starts, I guess, with that high level specification to say 
that is what we expect. We didn’t get that in the beginning.  It started with a 
discussion, as do all these pieces of work, especially when they’re quite 
new to us…so I think to write a good high level specification to inform the 
people, this is what we would expect, this is what we would expect the 
interface to do, this is what we want do with the results. 
 
Importantly, this reflected the desire for the IT specialists to be able to make sense of 
work on the app as a project. Once projectified in that way – and establishing a clear 
specification formed an important part of that – it made it easier for IT specialists both 





Team members reported different experiences regarding the mode of information-
sharing. Some found a shared drive useful, whilst others reported that it was limited 
because it was not kept up to date: 
 
[IT Specialist 12]: there was a spread sheet that was produced which was to 
act as the one true statement of [work needed and done] … But that wasn’t 
necessarily kept up-to-date.  That was also a weakness; so clear specification 
and then keeping the specification document up-to-date. 
 
The shared drive itself might be viewed as a boundary object (a standardized form, 
according to Star’s original definition (Star and Griesemer, 1989)). Its failure to retain 
its function in this role when not maintained resonates with Levina and Vaast’s (2005) 
argument that designated boundary objects fail to become boundary objects-in-use 
when they are not incorporated into every day practice. In contrast, an alternative 
mechanism emerged as a more useful means of collaboration and integration: 
 
[IT Specialist 5]: On other projects, between organizations, it’s been quite 
hard to have one place where people can see, but this Google Document 
thing just got rid of that issue, and everybody could log onto it, they could 
change it, they could see it, they knew who was doing what, everybody’s 
number was on there.  That was very handy and people have come back 
to me and said: ‘That was very handy’, and people have come back to me 
and said:  ‘That was really good, that was really good. 
 
Integration of data from the app involved close liaison between software developers 
(who designed the app), and hospital IT staff (who enabled the flow of app data into 
the EHR). Hospital IT staff recognized there was a boundary between these groups 
and drew upon their previous experience in emphasizing that external partners 
commonly underestimated the amount of work involved in integrating data into the 
EHR. This led to the recognition that fostering a shared understanding regarding the 




[IT Specialist 6]: It’s very typical in that sense, from a starting point of them 
not knowing the EPR that way. Or us not knowing what they’re going to do, 
trying to work a way to what is this really going to look like and generally 
the scope expands.  The work expands, and we understand that’s always 
likely to happen, that whoever walks in my door, and says, ‘I just want a 
document in the EPR, it should be a ten minute development, can we start 
next week’, and then it turns into a six month project, with all sorts of 
automated alerting and complex interfaces.  So this was very typical ... sort 
of what we expected. 
 
In this first section, we began with the different requirements of patients and 
practitioners, and how these were mediated. We then saw how members of different 
disciplines involved in developing the innovation were aware of, and tried to bridge, 
the boundaries between them. Clarity of role and project specification were regarded 
as key to enabling successful collaboration in this respect. The app itself served as a 
primary boundary object (Nicolini et al, 2012) that both inspired and helped sustain the 
collaboration needed.   
 
Boundary between the disease management led by the patient at home, and 
that planned in the clinic 
 
This second section acknowledges the traditionally hard boundary between patients 
and clinicians, and how the innovation mediated this, resulting in it becoming fuzzier. 
Initially we consider how the app empowered patients to self-manage their illness, 
although there were some limitations to its functionality. We then focus on how the 
graphs mediated the relationship between patients and clinicians during the 
consultation, acting as a boundary object-in-use between patients and clinicians, 
highlighted through a number of observed clinician-patient exchanges. The result was 
more focused and individualized care for patients, which might be seen to meet the 
current policy agenda for more patient-centred care (NHS England, 2014).  
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Empowering patients’ self-management 
Patients have responsibility for the ‘self-management’ of their RA between clinic visits 
for which there is no set formula, with a range of activities (e.g. exercise, pacing, joint 
protection and adaptations) being employed. There was consensus amongst patients, 
clinicians and managers that use of the app had the potential to enhance patient self-
management. This came across strongly in interviews and from the interactions 
observed between patients and clinicians during consultations. This was, in the main, 
an unexpected finding, and testament to its impact as a boundary object, as the app 
itself did not offer any advice or prompts for patients to change their behaviour.  
 
Patients reported that the simple act of entering data into the app encouraged them to 
reflect upon their RA, leading to better understanding of their illness. Some reported 
that the pattern of completing it, in conjunction with a diary function (which remained 
private to them and was not integrated into the EHR) enabled them to identify and 
therefore avoid potential triggers for flares, or fluctuations, in the severity of their 
symptoms.  
 
[Patient 2]: If I hadn’t have had the diary aspect, I might have remembered 
that I’d had a bad couple of days, but I probably wouldn’t have remembered 
that I’d been poorly for a few days with a really bad cold, leading up to that.  
I might have just said, oh yes, I had a couple of bad days.  And, he might 
have said, anything trigger it?  Oh, no, I was alright, because you forget 
don’t you? […] So, because I’ve got, like, the diary thing, I found that really 
helpful. 
[Clinician-researcher 1]: They said oh well, I realized that I'd been doing 
gardening that day. And the diary function helped them to see the pattern, 
so that kind of thing.  
 
Both parties felt that the increased self-awareness arising from interaction with the 
app, led to a feeling of empowerment for patients:  
 
[Clinician-researcher 2]: And I definitely saw that, that people were, kind of, 
more empowered to look after their own health.  Not through necessarily 
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doing anything as a result of it, but just that increased awareness seemed 
to, kind of, give them more control and they reflected positively on that.  
Acting as ‘confidante’ 
Some patients used the diary function as a safe space in which to record thoughts and 
emotions relating to their disease. As anticipated from interviews during the 
development of the innovation, several expressed this as being akin to having a 
‘confidante’. The simple act of documenting thoughts and feelings became a coping 
mechanism in itself. 
 
CONSULTATION:  
[Patient 2]: Keeping that diary has sort of, you know, you are just sort of like 
let it go – even if it's only one word like shit, you know, sort of nobody is 
going to see that, but you get it out there and it makes you feel good if you 
say something horrible you can say it to dear diary. 
Worsening healthcare anxiety 
Whilst daily patient data entry was felt by many patients to be beneficial in managing 
their illness, it is important to consider the potential for unintended consequences. A 
minority of patients (post-app) and practitioners (pre-app) noted that the app might 
worsen anxiety, forcing patients to think about RA when they might prefer not to. This 
unintended effect is very much in line with findings on telehealth interventions for 
COPD (Brunton et al., 2015).  
 
CONSULTATION:  
[Patient 23]: I suppose the only downside, well…my wife said to me, she 
wondered by sitting every morning poring over that and looking…self-
diagnosing…as I say, I had one really bad day about three weeks ago.  
Really down in the dumps, which … was, you know, what the hell’s 
happened?  Where’s my life going to?  A really crap day to put it brutally.  
And I got over that, but she wonders sometimes with…by doing this it’s 
days…you’re diagnosing… 
[Clinician-researcher 1]: You’re focusing on it more. 
18 
 
[Patient 23]: It’s in focus more…Does it make me more anxious? That’s the 
only downside really.  
At the same time, the surfacing of these anxieties could in itself be seen as a way in 
which engaging with the app prompted conscious reflection by patients on their 
condition and related moods. 
Using problematic scales 
Despite enthusiasm for the app, limitations regarding the scales used to represent 
patients’ disease activity were also identified. Patients felt that reducing their illness to 
scores was problematic. Frequent reference was made to the fact that RA does not 
occur in isolation and that it was difficult for patients to score ‘accurately’ because of 
the overlap of symptoms with other illnesses, and from the stresses and strains of life 
in general. Clinicians use similar scoring systems during consultations which are 
heavily relied upon in determining access to expensive treatments for RA. This reveals 
a tension between the clinician’s need to provide an ‘objective measure’ of disease 
activity, and the difficulty in disentangling the illness from the myriad other influences 
on patients’ health and wellbeing.  
 
[Patient 24]: I read the question and the first thing that came into my head I 
answered, but I have great difficulty because some of it’s rheumatoid and 
some of it’s osteo[arthritis].  And I don't know how - but it’s how I felt very 
genuinely, I’m not quite sure it was all rheumatoid.  
[Practitioner 10]: Yeah, well it’s just like if a patient comes to the clinic and you can 
actually see what’s going on and you can look at like the clinical manifestations, 
but if they’re self-reporting things then would they be reporting pain that isn’t down 
to their inflammatory disease because some of these patients do have other issues 




In this respect, the scoring system that was integral to the app, like any scale-based 
subjective scoring system, had its limitations. Nevertheless, by the same token, its 
plasticity did enable the translation of patient symptoms into clinical data that, as will 
be seen, could then feed into consultant-patient interaction in consultations.  
Boundary object between patients and clinicians  
Our analysis here centers on how inclusion of data from the app into the EHR affected 
the nature of the patient-doctor consultation. Particularly important here were the use 
of graphs of data generated from the app, which formed the centerpiece of the 
consultation process. 
 
In order to appreciate this, it is important to understand first the unique value in having 
this rich data available to the consultation. RA is a fluctuating illness and consultations 
have, until now, been limited both by the singular assessment being made, and the 
paucity of information available from the period between clinical consultations. Data 
from the app filled in these gaps, providing a bigger picture of what had happened 
between consultations, aiding patients’ recall and enabling the identification of events 
that might otherwise have been missed. 
 
Practitioners who were interviewed prior to development of the innovation felt that it 
would likely lead to a more collaborative, shared decision making process: 
 
[Researcher 1]: It kind of just encourages more of that kind of collaborative 
effort and managing their symptoms.  You look back and say like well before 
you started on Methotrexate, this is what your disease was like, and not just 
have like a one-off figure to show them.   
 
In enabling visualization of patients’ RA symptom activity, graphs were used to aid 
communication between patients and clinicians. These graphs effectively translated 
data from daily life into something more meaningful for each group. Patients reported 
that it took the burden of communicating their illness to the clinician away from them, 
in essence transforming their experience into something meaningful for clinicians. The 
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app was therefore crucial in actin as a mediator across this pragmatic boundary 
(Carlile, 2002):   
  
[Patient 8]: [Clinician researcher 1] showed me the graph and you could 
see where it had shot up and then it sort of did that. So you could actually 
see it, which clarifies it, but clarifies it also for the person looking at it; 
because they can see rather than saying, oh well, how did you feel? […] it’s 
a real tool to be able to show somebody else what you are going through 
because it’s very difficult when you go.   
 
Clinicians were familiar with viewing graphical data (e.g. blood test results) in the same 
format which aided engagement, and they incorporated the task of checking the 
graphs into their routine prior to patients entering the clinic room. They used the 
information gained as a comparator with patients’ responses to questions, probing 
further if inconsistencies between the two were apparent.  
 
CONSULTATION:  
[Clinician researcher 1]: So this is the three months.  So that’s August, this 
is October and this is the graph of your pain.  So the reason I was asking if 
there’s anything that had happened, any specific thing… 
[Patient 23]: Oh I’ll tell you what… 
[Clinician researcher 1]: … in all of your graphs, there’s a, kind of, peak 
between August and September in the same place………..So there’s…I 
suspect there’s something happened to you through, sort of, the latter half 
of August… 
[Patient 23]: Right.  I’m trying to think what that would be […] I know, end 
of August.  Tell you where I went then, I went to Edinburgh.  My daughter’s 
an actress and we went to The Fringe for a couple of days, which is fantastic 
but I over did it.  I’ll be honest.  I did 
 
Clinicians also felt that it helped them to communicate their perspective, backing up 
their viewpoint with ‘evidence’ from the graphs to emphasize a point to patients. This 
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was not only with regard to treatment interventions but with more subtle aspects of the 
doctor-patient relationship:  
 
[Clinician researcher 1] She was very stoical, and some people you can tell 
they're stoical […] But then other people you can't tell that in a two-minute 
assessment of a personality, because that's difficult. But her charts did 
show a number of peaks and I said to her actually, you're telling me you've 
been fine but these are suggesting that you've been less fine. And then we 
had quite an open conversation. I was able to say to her look, you're coming 
here telling me something that appears to be quite different to what you're 
recording. I don't know if you're aware of that or not….So it was quite nice 
to be able to have that with some evidence to say look, you're not fine, this 
is telling me you're not fine.  
On the one hand, the use of the data in this way could be seen as effectively reinforcing 
clinical practice and influence in the consultation process. On the other hand, as will 
be seen, it could be argued that it also meant some transformation of practice on the 
part of clinicians, who were able, through the graphs, to engage more effectively with 
the patient and their experience of the condition.   
Shared consultation 
Having seen how the graphs helped each party to communicate their perspective, we 
will now describe their role in creating a more shared consultation. Patients expressed 
surprise and delight at seeing ‘their’ data appear in graphical format on the clinicians’ 
screen. That it now appeared outside their smartphone and in their electronic record, 
for some, validated it and made it seem more official.  
 
CONSULTATION: 
[Clinician researcher 2]: So I've had a look through the results, let me just 
turn the screen around so you can see it as well.  So those results that you 
have get sent into the record and then we can make graphs of it. 
[Patient 24]: What, you’ve got them already here? 
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[Clinician researcher 2]: Yeah, so I've got them there, I can see them.  I've 
seen them already, so I'm asking you these questions knowing the answer 
to some of them. 
[Patient 24]: I didn’t realize that they’d come through… 
 
Clinicians reported that using the graphs led to a more shared consultation. Not only 
was the content of the discussion altered, but the nature of the consultation had also 
changed, both topically and physically, as they debated events rather than there being 
one-way reporting from patient to clinician:   
 
CONSULTATION:  
[Clinician researcher 1]: And so, you are right that there is quite a significant 
sort of day to day fluctuation so that is three out of ten down here and that 
is seven out of ten up here..[…] 
[Patient 12]: It’s funny on this, you can see the trend can't you? 
[Clinician researcher 1]: Yes, absolutely.  So... 
 
Similarly, from a clinician’s perspective: 
 
[Clinician researcher 2]: The patients really engage with that, they seem to 
understand graphs perfectly well. So the computer can potentially be a 
distraction, but I think it’s more of a distraction if I’m buried behind the 
computer, the computer as a discussion point worked well. 
Learning tool 
Patients and clinicians both reported that they learned from the graphs. For example, 
a clinician reported that the graphs demonstrated to them the impact of a simple 
intervention (e.g. providing compression gloves). This kind of contemporaneous data 
was not normally available, meaning that they were previously unable to appreciate 
the extent and immediacy of the patient benefit. In another example, a patient reported 
that seeing a gradual trend in improvement in response to a medication had persuaded 
them of its utility.  
 
[Clinician researcher 2]: [Following the intervention…] her pain graph got 
much better, as did her coping and her physical activity in the tasks that she 
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was able to perform, and clearly her whole life was transformed by this 
intervention, and that taught me the extent to which such interventions are 
useful 
 
Clinicians reported that graphical representation of some of the traditionally less 
clinical features of RA such as low mood, fatigue and sleep, raised the profile of these 
features, helping them to develop a deeper understanding of the more holistic impact 
of disease flares and fluctuations than perhaps they might otherwise have had. This 
increased awareness led them to open up the consultation to discussion of these 
issues. In tandem with this, having completed the app data on these ‘less clinical’ 
features and seeing them on the screen, patients felt empowered to talk about features 
that they might otherwise have felt unable to raise.  
 
[Clinician researcher 2]: It was interesting to me that patients …saw the 
kind of formal reporting across a range of different fields as being useful to 
support the consultation, but also a way into certain discussions they felt 
they didn’t have a way into, normally. 
The app as boundary object between patients and their relatives 
Patients who chose to share their app diaries or their disease activity scores outside 
the study, talked about how the app also helped to mediate the boundary between 
themselves and their relatives. In sharing this data with friends or relatives, patients 
reported that they felt better understood, without needing to offer lengthy explanations 
or justifications for how they were feeling. Again, this provided a compelling example 
of the app transforming knowledge and promoting learning (Carlile, 2002) – by 
removing the burden from patients of trying to explain their symptoms and enabling 
relatives to gain a more complete and informed picture of their condition.  
 
Looking at the boundary between innovation and practice, this second section has 
highlighted several examples of the innovation providing the centrepiece for 
collaboration between clinicians and patients. As such, it was clearly fulfilling the 
criteria for being considered a secondary level object (Nicolini et al., 2012). We have 
seen how both the app itself and the resultant graphs generated in the EHR acted as 
interconnected boundary objects (Scarbrough et al., 2015), allowing collaboration 
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between patients and clinicians. This collaboration occurred in ways that might have 
been expected (better communication – which was the primary technical goal of the 
app), but also, unexpectedly, in the process allowing each party to learn new 
information and develop better understanding of each other’s perspective.  
 
Boundary between the implementation of the app from a single research clinic 
to wider scale up  
This third section examines the prospects and challenges faced in moving from 
localized adoption of the innovation during this ‘proof of concept’ study, to adoption at 
scale. Three areas emerged as important enabling and inhibiting conditions: first, the 
relationships necessary to ensure the adoption of the innovation; second, resourcing 
issues; third, the technical challenges of integration with wider HER systems and 
possible corresponding solutions. 
Relationship considerations 
Developing the app and bringing together the relevant stakeholders had involved a 
good deal of championing of the initiative with clinicians and other groups and 
considerable effort in building close working relationships. Such challenges are 
common in the implementation of any healthcare technology innovation and here they 
needed to be replicated n a wider scale: 
  
[Manager 2]: … thing that would be really important would be clinical 
engagement and local champions, so if you were trying to use this in 
another environment the people trying to use it would really have to believe 
that it made a difference, and how you do that would be potentially difficult.  
But again I suppose ultimately it would be local networks of likeminded 
colleagues who’d try and implement on other sites. 
 
IT specialists and managers shared the view that building upon the pre-existing 
relationships nurtured during the development of the innovation would facilitate 
successful scale-up. IT specialists commented on the high level of clinical leadership 
which was felt to be vital to the success of the initiative and whose replication would 
enhance the likely success of any future project. In addition, the need for expertise in 
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various facets of the implementation process was noted, particularly with regard to 
app developers who were external to the NHS: 
  
[IT Specialist 12]: I think there’s no substitute for experience in terms of 
having experience with working on these kind of research projects 
integrating with NHS systems.  I think for just any old app developer coming 
along I doubt that they could pick up a toolkit and suddenly know everything 
they needed to know about how to make this work, it’s quite specialist really. 
 
In considering scale up of the innovation, managers acknowledged the role of 
early adopters of technology, with strong support needed for those who might 
need more persuasion to engage. 
 
[Manager 2]: That’s why I talk about networks and personal contacts, it’s 
going to have to be a rheumatologist in another hospital knows 
rheumatology in this one, and they’re willing to adopt what is seen as 
emerging technology and is seen as being very much patient-centric and 
improving patient outcomes. 
 
Clinicians felt that the benefits outweighed the burden of time taken up, and that this 
would likely enhance the likelihood of any future uptake. Patients, on the other hand, 
expressed concern that less forward-thinking clinicians might not engage with this kind 
of technology. This does highlight a tension, as patients and clinicians may well view 
telehealth interventions differently (Brunton et al., 2015). Although this was not the 
case here (as practitioners felt that the innovation represented a natural progression), 
such an attitude clearly might not generalize to other healthcare settings. 
 
IT specialists and managers also reported that the increasing e-literacy amongst 




[IT Specialist 5]: The populous in general are becoming more technology 
savvy, so most people have smart phones, they can download an app, and 
they can work an app quite proficiently. 
 
Indeed, some managers felt that scaling up the system might rely on patients to 
champion uptake of the app in order to encourage others to do so. Patients themselves 
reported that they would advocate the app to others, notwithstanding some 
challenges, including the difficulties in capturing RA disease activity using scales. 
However, both patients and clinicians questioned whether or not patients would 
continue to remain engaged in the long term, particularly if their disease was relatively 
stable and entering data regularly appeared to have less obvious benefit or meaning 
for them. These concerns mirror those made by patients prior to development of the 
innovation, who expressed a preference only to enter data when something notable 
had occurred. The more general point is that such enthusiasm would need to 
somehow transcend this particular case, if the app was to have the same 
corresponding impact elsewhere. 
 
Clinician researchers also expressed some concern regarding the potential for 
healthcare professionals to become too reliant on the app data, forfeiting a thorough 
history in favour of dependence upon the graphs. Interestingly, this points again to the 
potential impact of the app in transforming aspects of clinical practice. They were also 
concerned whether patients who did not engage with the app were it rolled out 
wholescale, would be penalized for a new form of patient ‘non-adherence’ (a phrase 
which has traditionally referred to a failure to adhere to medication and other treatment 
plans). Neither of these concerns were played out in this study. However, they again 
demonstrate potential inhibiting factors related to the latent capabilities of the object 
in question. 
Resource considerations 
Both clinicians and patients saw the prospect of altering appointment scheduling 
based upon app data as an opportunity for more patient-centred care, but were 
concerned about the logistics involved and where the responsibility for triggering an 
episode of care would lie.  Currently, secondary care organisations are remunerated 
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for each clinical consultation, so the interactions with app data, required for triaging 
appointments, would not be accounted for.  Managers recognised that scale up of the 
innovation, with this kind of impact on service provision, would require changes in 
commissioning practice, but were broadly in favour if it meant that potential savings 
were realized: 
 
[Manager 3]: I mean everything else is focused on cost and efficiency at the 
moment, and the driver for anything like this, the largest driver will be efficiency.  
So if we can follow up patients more efficiently that’s going to be very attractive. 
 
Maintaining the system once the innovation had been adopted, also raised issues of 
funding and personnel to support and sustain the innovation in the long term.  
 
[IT Specialist 9]: So I think from our point of view in terms of scaling that up. 
That’s a greater advantage to us to scale it up, but again, it comes back to 
how well can it be supported?  Do we have the resources to do that?  What 
would be the maintenance overhead?  You know, is there any capital cost 
attached to it in terms of how long a life we can expect from this app and 
what do you do then for revisions? 
 
From a pragmatic perspective, managers were concerned that increased patient 
anxiety (the potential for which was discussed above) might lead to an increase in 
consultation rates; 
 
[Manager 8]: There’s a wide spectrum of patients and we all know that some 
patients by sheer fact of actually giving them a focus on a particular aspect 
of their health increases the number of times they are likely to consult.  So, 
is it actually giving them far too much of a focus on that particular aspect 
and, therefore, they are recording just about everything and the 
psychosomatic side of symptoms really. 
Technical considerations 
IT staff and managers both acknowledged that being a ‘digitally mature organisation’ 
was key to the success of future ventures, although managers’ views were more 
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muted, with digital maturity being ‘nice to have’ rather than a pre-requisite for success 
as an organisation. 
 
[IT Specialist 6]: So, the issues you’ll have will be the level of digital maturity 
… Technology is the same pretty much wherever you go across the world.  
The challenge would be whether their EPRs are mature enough to be able 
to do the sort of things that you want to do, whether they have that capability 
within the interface team. 
 
Stakeholders identified a need to ensure that the app and associated infrastructure, 
particularly with regard to integration into the EHR, was as generic as possible, in 
order to maximize the chances of scaling up the innovation. Standardized ways of 
working were felt to improve the potential to integrate with a number of different IT 
systems, highlighting a real tension as boundary conditions varied between the project 
and IT systems.  
 
[IT Specialist 6]: I can get my interface people to build an interface that will 
gather the pathology from each trust, but each one of those interfaces will 
be a point-to-point connection, it will be a bespoke development and a 
lengthy development as well … But if everyone fed their information into a 
centralised port then we could all take it out. So we all build one interface 
in and we all build one interface out.  So, it’s getting agreement about 
standardisation, standardized way of working will enable us to move at a 
much faster rate.  There is a danger we tend to get too focused on bespoke 
pieces of work. 
 
At the same time, the need to incorporate more ad hoc interfaces was recognized: 
 
 
[Manager 2]: It was a sort of ad hoc interface that was built, and what we 
need to be doing as a trust, as we are doing, is making sure that those 
interface and interoperability is in the right place for devices such as [the 
app] to interact with us.  So we have an obligation, if you like, as a provider 
trust to try and move our infrastructure towards being compatible with 
those.  And I suppose it probably needs on-going review, doesn’t it, in terms 
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of when we upgrade we need to then check with all the systems which we 
interface with that actually that still works, and I think we don’t know, to be 
honest. 
 
In other words, the localized development of the app had been what had galvanized 
interest and been made possible through a logic of a bespoke design that flexibly 
met specific patient group and diagnostic needs. But, the real value was in widening 
that out (to other hospitals, other disease areas) and that required an approach that 
reflected a logic of standardization and efficiency.  
 
Both IT staff and managers were concerned to ensure that the project might have 
long-term sustainability, in order to justify scaling it up. The limitations of the study 
developing an isolated research innovation rather than a longer term programme of 
development, was identified. 
 
[IT Specialist 13]: For us, [the app] is a short tem project.  There’s been no 
mention of turning it into a product as it were.  It’s a research tool.  If you 
wanted to turn it into a product then, yes, you need people to regularly 
update components, make sure it still works on the new smartphones and 
what have you.  There’s no easy silver bullet for that one. 
 
In other words, the projectification that had served the initial development of the app 
so well was now insufficient for, or even potentially inhibiting of, its wider roll out. 
 
Finally, IT staff identified that the development of the app by software developers 
working independently from the EHR team, meant that their compatibility following 
future updates was also at risk. 
   
[Manager 2] We need to know that it works and that it interfaces with our 
systems.  So I know that with [the app] I think a specific interface has been 
built into the electronic patient record. But from the middle of next year with 
our EPR upgrade we’re looking at [compatibility] so that these devices can 
talk to us more reliably.  So I suppose at the minute the interface is 
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unreliable.  Where there are upgrades to the EPR [EHR] it can become 
technically more difficult to reformat that upgrade. 
 
This third and final section of the analysis has highlighted three sets of boundary 
conditions affecting the successful scale up of this innovation. These important 
enabling and inhibiting conditions – inter-disciplinary relations, resources and 
technical infrastructure – represented important tertiary level conditions that related to 
the wider infrastructure with which, ultimately, the app needed to interconnect. The 
main point to emphasize here is that the transformation of knowledge and practice that 
was so central to the development and use of the app paradoxically created conditions 
whose replication was necessary – but potentially more challenging – if the innovation 




Analysis of the development of this innovation (which included the app and associated 
graphs), and attempts to generalize its application to other settings, throws up a 
number of important conceptual and practical implications.  
 
First, that the development of the innovation across the boundary between innovation 
and practice, can be seen not just as a technical achievement, but also as an ongoing 
social accomplishment. That is, the object created a focus around which communities 
with quite distinct purposes, practices and perspectives could work, developing and 
deploying a common tool to achieve a common purpose (cf. Nicolini et al, 2012). The 
case demonstrated the importance of clarity of both project specification and personal 
role, in order that individuals from distinct (albeit closely related, in the case of software 
developers and IT specialist) communities might work together. However the 
innovation itself, as a primary object around which these communities who worked 
towards a shared purpose of app development coalesced, was not sufficient to enable 
them to accomplish this goal, with the need for individuals on the project team to act 
as brokers becoming clear. This echoes findings of (Sapsed and Salter, 2004) who 
identified that boundary objects cannot function without human interaction. In addition 
to the need for a brokering role, other boundary objects, such as the shared-drive, also 
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required updating in order to fulfil their potential as a boundary object-in-use (Levina 
and Vaast, 2005). 
 
Second, and by the same token, making the system work in practice at local level was 
challenging since the design of the app inevitably contained within it certain 
prescriptions that, while they had normative value in promoting a common purpose 
(e.g. meeting patients’ needs), also potentially conflicted with existing system and 
organizational imperatives (important for the efficiency of healthcare delivery). At a 
local level, this would ensure that the project required continuing action not simply to 
explain and justify any technical, clinical or administrative accommodations required, 
but also to sustain the coalition of interests involved in its design and implementation.  
 
We saw that the app empowered patients to have greater awareness of their RA 
condition. Parts of the innovation as boundary objects-in-use really came to light in its 
role liaising between patients, and their relatives (app) and healthcare professionals 
(graphs), respectively (Levina and Vaast, 2005). That these two linked aspects of the 
innovation worked together as boundary objects is redolent of Scarbrough’s (2015) 
findings on the systemic interconnectedness of boundary objects. It also demonstrates 
how, through transforming the nature of the diagnostic and consultation processes, it 
also unsettled normalized relations of power. It did so in two main ways: first, by 
challenging systems of generalized care and standardized information flows to allow 
for bespoke treatment. Second, by providing evidence for patients with which they 
could more effectively communicate with healthcare professionals, shifting the power 
dynamics within the consultation. The nature of the revised clinical consultation 
certainly created expectations on patients to provide a more accurate and salient 
version of events, but it also empowered them to take more control of their diagnosis 
and treatment. Moreover, it also created expectations on clinicians to demonstrate the 
utility of treatments and to appreciate the need for more open consultations that 
addressed less clinical features – even where that might not make a material 
difference to the patients’ disease activity. These were unexpected findings in how the 
use of the app disrupted existing clinical diagnostic and treatment practices. This use 
of the innovation to cross this complex pragmatic boundary (Carlile, 2002) was not 
dissimilar in effect to Nicolini et al’s (2012) depiction of the effects of secondary 




Lastly, the innovation provided the opportunity for learning by both stakeholders; 
patients learned about triggers for disease fluctuations and clinicians learned about 
the impact of interventions and the value in addressing ‘non-clinical’ topics. The 
obvious challenge here for this, with implications for taking the project forward, is that 
what here was seen as patient empowerment and clinician changed practice, could 
elsewhere be seen simply as a threat by clinicians who might prefer or insist on more 
traditional, paternalistic models of clinical consultation. As such, its more disruptive 
effects were both a sine qua non of its development and application, but also a 
potential, boundary to its wider diffusion. While such challenges might be manageable 
at a local level, given the strength of local relationships and commitments 
demonstrated in our findings, extrapolating that to other contexts, transgressing the 
boundary between implementation of the app to wider scale up would likely be 
extremely difficult. There would likely be significant challenges to existing 
power/knowledge configurations that the roll out of the initiative would inevitably 
surface (cf. Newell et al., 2003).  
 
As well as the direct impact upon established clinical professional practice noted 
above, we identified challenges to the long-term sustainability and scaling up of this 
innovation at a tertiary level (Nicolini et al, 2012) associated with three wider sets of 
infrastructural conditions – namely, interdisciplinary relations, resources and technical 
infrastructure. Firstly, the importance of strong clinical leadership and the need to build 
upon existing networks and relationships were considered the key to future attempts 
to scale up the innovation. Secondly, managers in particular noted that organizational 
change would be required with regard to the manner in which services are 
commissioned and all stakeholders expressed concern about the resource 
implications of sustaining the innovation. Finally, at a technical level, participants 
stressed that creating and utilizing generalizable and generic IT solutions would 
enhance the chances of ambitions to scale up the project.  It should be noted that the 
focal hospital is an early adopter of information technology development and is known 
for its status within healthcare as a digital exemplar. Moreover, the availability of 
external research funding meant that undertaking this particular project was able to be 
prioritized by busy IT staff. These factors acted as facilitators in our case. They make 
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the prospect of scaling it up to other, less digitally mature organizations with fewer 
financial resources, clearly more challenging.  
 
The overall implication is that boundary objects such as the app in question may have 
powerful integrative effects at certain points or stages in both its development and use. 
However, it may also suppress key differences in interest and perspective whose 
latent disruptive effects may emerge at other points or stages in the developmental or 
implementation process to inhibit further development or wider application (cf. Barrett 
and Oborn, 2010). More generally, it is important to see the development of the object 
as embedded within, and inevitably shaped by, the (shifting) constellation of social 
interests, relations and perspectives brought by each community of practice to the 
project. This of course has implications too for wider attempts to reconcile the 
embedding of new (technical) initiatives in local practice with the need to generalize 




In this paper, we have used the concept of boundary object to explore processes of 
collaboration, knowledge transformation and learning associated with the 
development, use and diffusion of a particular type of healthcare innovation, co-
developed by clinical researchers with their patients. The use of boundary object 
theory to interrogate the development of technological innovations (Barrett and Oborn, 
2010, Levina and Vaast, 2005, Swan et al., 2007) and to understand the mediation of 
relationships between healthcare professionals (Allen, 2014, Keshet et al., 2013) has 
been explored previously and is not in itself new. However, in interrogating both the 
development and shaping of this innovation over time and in exploring the 
development of the object as it became (re-)positioned as a boundary object-in-use, 
the work has built on recent attempts to understand the development of technological 
artefacts situated in systems of inter-connected objects and relations (Nicolini et al, 
2012; Scarbrough et al, 2015). Specifically, it has demonstrated how the integrative 
and learning potential associated with such innovations in their (co-)development and 
use (cf. Carlile, 2002, 2004) paradoxically also inhibit the (potential) application and 
diffusion of such technology on a wider system basis. As such, the integrative and 
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Table 1. Summary of sources of data sources 
Stakeholder / key Timing Interactions 
Practitioner Pre-app 3 x semi-structured interviews 
1 x focus group  
(4 consultants, 3 specialty trainees)  
Researcher Pre-app 10 x semi-structured interviews 
IT specialist Pre-app 1 x semi-structured interview 
1 focus group (6 members) 
Manager Pre-app 6 x semi-structured interviews 
Patient Post-app 16 x semi-structured interviews  
Clinician researcher Post app 3 x semi-structured interviews 
(2 with WD: 1 with CAS) 
CONSULTATIONS Post app 17 recorded clinical consultations (between 
clinican researchers and patients) 
40 
 
Table 2. Thematic analysis summary 






BOUNDARY BETWEEN INNOVATION AND PRACTICE 
Patient input into 
design 
  App to help identify 
triggers, to act as 
confidante 
Data entry of notable 
events 
Preferred daily data 
capture 
Preferred daily data 
capture 
Clarity of role Importance of role clarity; 
use of brokers 
    
Clarity of specification Importance of clarity of 
specification (not always 
easy to achieve across 
professional boundaries); 
mixed success in use of 
boundary objects e.g. 
shared drives in 
achieving this 
    
BOUNDARY BETWEEN DISEASE MANAGEMENT LED BY THE PATIENT, AND THAT PLANNED IN THE CLINIC 
Empowering patient’s 
self-management 
 Potential to enhance self-
management 








Potential to enhance self-
management 
 





  Potential for app use to 
worsen anxiety 
 Potential for app use to 
worsen anxiety 
Scales problematic   Scores felt to be 
reductionist 
Difficulty isolating 
symptoms caused by RA 
alone 
Clinicians require 




between patients and 
clinicians 
  Transformed patients’ 
experience into 
something meaningful for 
clinicians 









Reduced burden of 
communication 
Routinized use of 
graphical data 
Used this as an aid to 
history-taking 
Shared consultation   Validating patient-
entered data 




Learning tool   Highlighted benefits of 
particular interventions 
Empowered to discuss 
less-clinical features 
Highlighted benefits of 
particular interventions 
Increased awareness of 




between patients and 
relatives 
  Reduced burden of 
communication 
  
BOUNDARY BETWEEN THE IMPLEMENTATION OF THE APP FROM A SINGLE RESEARCH CLINIC TO WIDER SCALE UP 
Relationship 
considerations 
Importance of clinical 





Strength of experience in 
integrating research with 
NHS systems 






Need to capitalize on 
early adopters and 
support laggards 
Opportunity provided by 
patients’ increasing e-
literacy 
Use of patient champions 
Concerned whether less 
forward-thinking 
clinicians would engage 
Use of patient champions 
Questioning long-term 





engagement with data 
entry 
Potential risk of over-








Long term funding and 
personnel required to 
sustain 
Scale up would require 
changes to 
commissioning practice 
Long term funding and 
personnel required to 
sustain 
Increased patient anxiety 
might increase 
consultation rates 
Use for triaging 
opportunity for patient-
centered care; but where 
would responsibility lie? 
Use for triaging 
opportunity for patient-
centered care; but where 






Importance of digital 
maturity 
Generic infrastructure to 
aid scale-up 
Long-term sustainability 
important to justify scale-
up 
Issues of compatibility  
following updates 
Importance of digital 
maturity 
Generic infrastructure to 
aid scale-up  
Long-term sustainability 
important to justify scale-
up 
   
 
